While these methylation studies highlight the clinical relevance of C9ORF50 dysregulation in cancer detection, our functional data establish its direct pro‐oncogenic role in tumor progression, suggesting that its epigenetic silencing in accessible biospecimens may reflect field cancerization or secondary events rather than tumor‐suppressive function. Here, C9orf50 is linked to cancer.